The effect of TNF-alpha, FcγR and CD1 polymorphisms on Guillain–Barré syndrome risk: Evidences from a Meta-Analysis
- 29 February 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 243 (1-2), 18-24
- https://doi.org/10.1016/j.jneuroim.2011.12.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Fc receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2010
- Fcγ receptor polymorphisms and their association with periodontal disease: a meta‐analysisJournal of Clinical Periodontology, 2010
- Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G Genes Polymorphisms with Multiple SclerosisImmunological Investigations, 2010
- Association of Tumor Necrosis Factor Polymorphisms with Guillain-Barré SyndromeEuropean Neurology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and GlycolipidsAnnual Review of Immunology, 1999
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986